• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    8/22/23 1:49:58 PM ET
    $AGIL
    $AMC
    $ASLE
    $AXLA
    Professional Services
    Consumer Discretionary
    Movies/Entertainment
    Consumer Discretionary
    Get the next $AGIL alert in real time by email

    Gainers

    • Fulcrum Therapeutics, Inc. (NASDAQ:FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.
    • VinFast Auto Ltd. (NASDAQ:VFS) gained 42% to $24.96.
    • Axcella Health Inc. (NASDAQ:AXLA) shares climbed 37.3% to $0.2101 after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss.
    • Sidus Space, Inc. (NASDAQ:SIDU) shares gained 30.4% to $0.2101. Sidus Space acquired edge artificial intelligence company, Exo-Space.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) jumped 28.3% to $1.35.
    • Fabrinet (NYSE:FN) gained 25% to $146.01 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) gained 24.4% to $0.2002. Borqs Technologies received extension from CFIUS for HHE divestment, and will consider share buyback and/or paying a special dividend.
    • Hitek Global Inc. (NASDAQ:HKIT) gained 22.2% to $27.50.
    • 1847 Holdings LLC (NYSE:EFSH) climbed 18.7% to $0.1389.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) climbed 18% to $0.1862.
    • Renovaro Biosciences Inc. (NASDAQ:RENB) jumped 16.6% to $2.10.
    • 2U, Inc. (NASDAQ:TWOU) gained 16.5% to $3.39.
    • ProMIS Neurosciences, Inc. (NASDAQ:PMN) shares gained 16.4% to $1.84. ProMIS Neurosciences announced a $20.4 million private placement financing at $1.88 per unit.
    • MIND Technology, Inc. (NASDAQ:MIND) jumped 15.6% to $0.6851. MIND Technology announced sale of Klein Unit for cash consideration of $11.5 million.
    • Hallmark Financial Services, Inc. (NASDAQ:HALL) shares rose 15.4% to $3.38. Hallmark Financial recently posted a second-quarter operating loss of $6.83 per share.
    • Matrix Service Company (NASDAQ:MTRX) gained 15% to $7.35. Matrix Service Company announced receipt of $464 million of awards in the fourth quarter and ending backlog of $1.1 billion.
    • AMTD Digital Inc. (NYSE:HKD) jumped 13.8% to $5.69 after announcing a $30 million share repurchase program.
    • AerSale Corporation (NASDAQ:ASLE) gained 9.7% to $13.87. AerSale completed certification flight testing for AerAware Enhanced Flight Vision System (EFVS).
    • Freight Technologies, Inc. (NASDAQ:FRGT) rose 9% to $0.5441 after gaining around 4% on Monday.
    • Hasbro, Inc. (NASDAQ:HAS) gained 7.4% to $67.94. B of A Securities maintained Hasbro with a Buy and raised the price target from $85 to $90.
    • Super League Gaming, Inc. (NASDAQ:SLGG) shares rose 6.2% to $0.1277 after falling around 50% on Monday. Super League announced pricing of $2.2 million underwritten public offering of 16,923,077 shares of common stock at $0.13 per share.

    Losers

    • Republic First Bancorp, Inc. (NASDAQ:FRBK) shares fell 44% to $0.3920 after the Nasdaq notified the company that it will not be listed on the exchange because it has not filed its Form 10-K Annual Report with the SEC for FY22.
    • Tingo Group, Inc. (NASDAQ:TIO) fell 30.4% to $0.8254. Tingo Group said it further postponed its second-quarter earnings release and filing of its form 10-Q for the period ended June 30, 2023.
    • SOS Limited (NYSE:SOS) fell 27.5% to $6.49 after jumping over 99% on Monday.
    • AgileThought, Inc. (NASDAQ:AGIL) fell 25% to $0.23.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) fell 24.7% to $1.45 after the company reported downbeat second-quarter results and issued weak forecast for the third quarter.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares fell 24.2% to $0.1813 after gaining 60% on Monday.
    • DICK'S Sporting Goods, Inc. (NYSE:DKS) declined 24% to $111.79 after the company reported worse-than-expected second-quarter results and lowered FY23 guidance.
    • Mullen Automotive, Inc. (NASDAQ:MULN) fell 20.7% to $0.4924.
    • Motorsport Games Inc. (NASDAQ:MSGM) declined 20% to $3.71 following second-quarter results.
    • PureCycle Technologies, Inc. (NASDAQ:PCT) fell 17.3% to $8.14 after the company reported upsize and pricing of $215.0 million 7.25% green convertible senior notes due 2030.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 17% to $2.58.
    • Geron Corporation (NASDAQ:GERN) fell 15% to $2.2350. The FDA has assigned a standard review and a prescription drug user fee act action date of June 16, 2024 for Geron's new drug application for Imetelstat for transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes.
    • Society Pass Incorporated (NASDAQ:SOPA) fell 14.4% to $0.4198. Society Pass said on Aug. 21, that the company entered into sales agreement with Ascendiant Capital Markets for offering of up to $10 million common stock.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) fell 12.7% to $1.8498.
    • EBET, Inc. (NASDAQ:EBET) declined 12.2% to $0.0565.
    • MediaCo Holding Inc. (NASDAQ:MDIA) shares fell 12% to $0.66 after gaining more than 30% on Monday.
    • Macy's, Inc. (NYSE:M) fell 11.1% to $13.10 after the company reported second-quarter financial results.
    • Canadian Solar Inc. (NASDAQ:CSIQ) declined 11.1% to $27.36 following quarterly results.
    • Emergent BioSolutions Inc. (NYSE:EBS) fell 10.6% to $4.2550. Advance Auto Parts will replace Emergent BioSolutions in the S&P SmallCap 600, effective Aug. 25.
    • Nordstrom, Inc. (NYSE:JWN) declined 8.3% to $17.48.
    • iQIYI, Inc. (NASDAQ:IQ) fell 7.6% to $4.8050 following second-quarter results.
    • Kohl's Corporation (NYSE:KSS) declined 6.4% to $26.87.
    • V.F. Corporation (NYSE:VFC) fell 6% to $19.17.

     

    Now Read This: Toll Brothers Likely To Post Higher Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $AMC
    $ASLE
    $AXLA

    CompanyDatePrice TargetRatingAnalyst
    Hasbro Inc.
    $HAS
    2/25/2026$118.00Outperform
    BNP Paribas Exane
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    Fabrinet
    $FN
    2/4/2026$540.00Peer Perform → Outperform
    Wolfe Research
    V.F. Corporation
    $VFC
    1/29/2026$16.00 → $20.00Market Perform
    Telsey Advisory Group
    V.F. Corporation
    $VFC
    1/14/2026$18.00Hold
    Jefferies
    Macy's Inc
    $M
    1/14/2026$27.00Buy
    Jefferies
    Kohl's Corporation
    $KSS
    1/14/2026$22.00Hold
    Jefferies
    Fabrinet
    $FN
    1/14/2026$537.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $AGIL
    $AMC
    $ASLE
    $AXLA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    FDA Approval for RYTELO issued to GERON CORP

    Submission status for GERON CORP's drug RYTELO (ORIG-1) with active ingredient IMETELSTAT has changed to 'Approval' on 06/06/2024. Application Category: NDA, Application Number: 217779, Application Classification: Type 1 - New Molecular Entity

    6/7/24 12:36:59 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $AMC
    $ASLE
    $AXLA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hasbro Announces Pricing of Public Offering of Notes

    Hasbro, Inc. (NASDAQ:HAS) ("Hasbro") announced today the pricing of an underwritten registered public offering (the "Offering") of $400,000,000 aggregate principal amount of 4.650% Notes due 2031 (the "Notes"). The Notes will accrue interest beginning March 12, 2026 with semi-annual payments commencing September 12, 2026. Subject to customary closing conditions, the Offering is expected to settle and close on or about March 12, 2026. The net proceeds from the Offering will be $397 million, after giving effect to the underwriting discount but not estimated offering expenses payable by Hasbro. Hasbro intends to use the net proceeds of the Offering for general corporate purposes, including t

    3/5/26 4:55:00 PM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    AerSale® Reports Fourth Quarter and Full Year 2025 Results

    Fourth Quarter 2025 Highlights Revenue of $90.9 million versus $94.7 million in the prior year periodGAAP net income of $5.4 million versus GAAP net income of $2.7 million in the prior year periodAdjusted net income1 of $7.5 million versus adjusted net income of $4.8 million in the prior year periodAdjusted EBITDA1 of $15.2 million versus Adjusted EBITDA of $13.0 million in the prior year periodFlight equipment sales consisted of four engines compared to six engines in the prior year periodFeedstock acquisitions of $15.4 million in the quarter 2025 Full Year Highlights Revenue of $335.3 million versus $345.1 millionGAAP net income of $8.6 million versus GAAP Net Income of $5.9 millionAdju

    3/5/26 4:05:00 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    On-Orbit Imagery Milestone with HEO USA's Payload Aboard Sidus Space's Multi-Mission LizzieSat-3

    Images Captured by HEO USA's Non-Earth Imaging Camera Validate Integrated Sensor Performance in Orbit CAPE CANAVERAL, Fla., March 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, and HEO USA, a leading provider of non-Earth imaging (NEI) and analytics, today announced the successful receipt of a series of on‑orbit images from HEO USA's NEI camera aboard Sidus Space's LizzieSat‑3 (LS‑3). Sidus Space's LizzieSat‑3 validates integrated multi‑sensor performance with first on‑orbit imagery for HEO

    3/5/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $AGIL
    $AMC
    $ASLE
    $AXLA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Papa Joseph C covered exercise/tax liability with 37,055 shares, decreasing direct ownership by 11% to 305,445 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    3/5/26 9:40:29 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fowler John D Jr was granted 5,006 shares (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    3/5/26 9:38:11 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Fowler John D Jr claimed no ownership of stock in the company (SEC Form 3)

    3 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    3/5/26 9:37:49 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $AMC
    $ASLE
    $AXLA
    SEC Filings

    View All

    SEC Form FWP filed by Hasbro Inc.

    FWP - HASBRO, INC. (0000046080) (Subject)

    3/5/26 4:55:21 PM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    AerSale Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AerSale Corp (0001754170) (Filer)

    3/5/26 4:05:56 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    SEC Form 424B5 filed by Hasbro Inc.

    424B5 - HASBRO, INC. (0000046080) (Filer)

    3/5/26 8:44:28 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    $AGIL
    $AMC
    $ASLE
    $AXLA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Eugene bought $92,420 worth of shares (4,000 units at $23.11), increasing direct ownership by 63% to 10,397 units (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    3/4/26 6:08:32 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Development Officer Kaplan Johanne bought $25,005 worth of shares (1,629 units at $15.35), increasing direct ownership by 70% to 3,941 units (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    2/23/26 8:31:05 AM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Abg Management Ltd. bought $8,499,988 worth of shares (700,741 units at $12.13) (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    2/5/26 7:00:01 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $AMC
    $ASLE
    $AXLA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BNP Paribas Exane initiated coverage on Hasbro with a new price target

    BNP Paribas Exane initiated coverage of Hasbro with a rating of Outperform and set a new price target of $118.00

    2/25/26 8:51:16 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    V.F. Corp downgraded by Analyst with a new price target

    Analyst downgraded V.F. Corp from Neutral to Underweight and set a new price target of $18.00

    2/23/26 8:34:02 AM ET
    $VFC
    Garments and Clothing
    Industrials

    Fabrinet upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Fabrinet from Peer Perform to Outperform and set a new price target of $540.00

    2/4/26 8:55:11 AM ET
    $FN
    Telecommunications Equipment
    Utilities

    $AGIL
    $AMC
    $ASLE
    $AXLA
    Leadership Updates

    Live Leadership Updates

    View All

    Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

    GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026. Mr. Fowler brings more than three decades of leadership experience across the healthcare and financial services sectors. He will serve on the Audit and Finance Committee. "We're pleased to welcome John to the board of directors at this important point in the company's ongoing turnaround and transformation," said Dr. Zsolt Harsanyi, Ph.D., chairman of the board. "John's deep experience in healthcare and financial markets will provide valuable insight as the company continues to execute against i

    3/3/26 8:00:00 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kohl's Corporation Declares Quarterly Dividend

    The Board of Directors of Kohl's Corporation (NYSE:KSS) ("Kohl's" or the "Company") today declared a regular quarterly dividend of $0.125 per share on the Company's common stock. The dividend is payable April 1, 2026, to shareholders of record at the close of business on March 18, 2026. About Kohl's Kohl's (NYSE:KSS) is a leading omnichannel retailer built on a foundation that combines great brands, incredible value and convenience for our customers. Kohl's is uniquely positioned to deliver against its long-term strategy and its purpose to take care of families' realest moments. Kohl's serves millions of families in its more than 1,100 stores in 49 states, online at Kohls.com, and throu

    2/25/26 4:15:00 PM ET
    $KSS
    Department/Specialty Retail Stores
    Consumer Discretionary

    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

    Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), today announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd. ("Chemrex"). As part of this restructuring, Chemrex's board has been streamlined to two directors: Matthew L. Barsing, ChairmanAngeline Chong, Chief Financial Officer of BioNexus, Director New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates un

    2/23/26 8:30:00 AM ET
    $BGLC
    Medical Specialities
    Health Care

    $AGIL
    $AMC
    $ASLE
    $AXLA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Dragonfly Energy Holdings Corp.

    SC 13D/A - Dragonfly Energy Holdings Corp. (0001847986) (Subject)

    11/21/24 6:10:38 PM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by AMTD Digital Inc.

    SC 13G/A - AMTD Digital Inc. (0001809691) (Subject)

    11/14/24 9:33:22 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    $AGIL
    $AMC
    $ASLE
    $AXLA
    Financials

    Live finance-specific insights

    View All

    AerSale® Reports Fourth Quarter and Full Year 2025 Results

    Fourth Quarter 2025 Highlights Revenue of $90.9 million versus $94.7 million in the prior year periodGAAP net income of $5.4 million versus GAAP net income of $2.7 million in the prior year periodAdjusted net income1 of $7.5 million versus adjusted net income of $4.8 million in the prior year periodAdjusted EBITDA1 of $15.2 million versus Adjusted EBITDA of $13.0 million in the prior year periodFlight equipment sales consisted of four engines compared to six engines in the prior year periodFeedstock acquisitions of $15.4 million in the quarter 2025 Full Year Highlights Revenue of $335.3 million versus $345.1 millionGAAP net income of $8.6 million versus GAAP Net Income of $5.9 millionAdju

    3/5/26 4:05:00 PM ET
    $ASLE
    Industrial Specialties
    Consumer Discretionary

    Motorsport Games to Report Fourth Quarter and Full Year 2025 Financial Results

    MIRAMAR, Fla., March 04, 2026 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ:MSGM) ("Motorsport Games" or "the Company"), a racing game developer, publisher and esports ecosystem provider of official motorsport racing series, will report its financial results for the fourth quarter and full 2025 fiscal year on Tuesday, March 10, 2026 after market close. Management will host a conference call and webcast on the same day at 5:00 p.m. ET to discuss the results. Participants may access the webcast on the Company's investor relations website at https://ir.motorsportgames.com under "Events." This webcast will be available live and remain accessible as a recording for 12 months following the

    3/4/26 4:02:00 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    Macy's, Inc. to Report Fourth Quarter and Fiscal Year 2025 Results on March 18, 2026

    Macy's, Inc. (NYSE:M) will report its fourth quarter and fiscal year 2025 sales and earnings results on Wednesday, March 18. The company will host a call and webcast with financial analysts and investors at 8:00 a.m. ET. The call will be hosted by Tony Spring, Macy's, Inc.'s chairman and chief executive officer, and Tom Edwards, chief operating officer and chief financial officer. The general public and the media will be able to access the live webcast and associated presentation via the company's website at www.macysinc.com. To participate in the call, analysts and investors may dial 1-877-407-0832. A replay of the conference call will be available on the company's website or by dialin

    3/3/26 8:30:00 AM ET
    $M
    Department/Specialty Retail Stores
    Consumer Discretionary